Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice. - Wikidata - awgldk - TriplyDB

Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.

Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.

http://www.wikidata.org/entity/Q36688932

about

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination Trichosanthin increases Granzyme B penetration into tumor cells by upregulation of CI-MPR on the cell surface Cytokines in immunogenic cell death: Applications for cancer immunotherapy.CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens.Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

P2860

Q28068378-70DCCBD6-7AE5-4F0A-B3EF-1E3D8CC9191A Q33688705-C552CDCC-AECB-491E-A70B-300E0A2ECCAF Q39397491-99A5A152-F3AB-4775-9E01-12FFA32808C0 Q47285613-583772BD-6481-44AA-BE01-BFB5F1ADF74F Q47629566-C0C84043-CF93-4E02-AAC8-206AF4C41E94 Q48504970-D6FF4D66-0B97-462E-B56C-CECECC08B630 Q48535444-9F453071-80F0-4362-BF26-8ECCD5AD9D64 Q52758913-7CEA8045-78C5-40E3-BDFD-03B1FD6FB4F8 Q56594845-F70F2CE4-157D-4E6E-B550-863E3FE7E6AB Q58564259-70506DD4-12B5-40E8-B736-A611B65C052F

P2860

Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.

http://www.wikidata.org/entity/Q36688932

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@ast

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@en

type

label

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@ast

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@en

prefLabel

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@ast

Enhancement of adoptive T cell ...... rubicin or paclitaxel in mice.

@en

P1433

Q36688932-A17E5086-53B3-46B4-885E-21AF54E8B2B5

P1476

Q36688932-FA82AF9F-AD1E-4667-8798-CF4B01DCD168

P2093

Q36688932-47C12BA2-3112-40B2-9DB8-581B8C6AD356

Q36688932-8C0337F4-DF4A-4787-9979-CBA65C07AEFD

Q36688932-D32CE9CE-3992-4144-817B-75F58116BF78

Q36688932-F036CB63-D53A-454F-B6EC-DEBA05AC6C73

P2860

Q36688932-091D98E1-4377-4C7E-ADE0-FB91281A74BD

Q36688932-0A1C5F5E-77C3-4E67-B7EB-C5F619DA96B4

Q36688932-10FE2BF3-F384-4F8E-8304-1B0C3712618A

Q36688932-124D04F6-4F1F-4243-8A7D-BF514133B544

Q36688932-1CA3572D-7C53-4A55-886F-F016EBFB2E0A

Q36688932-1CC997DD-6E42-4D9B-8B90-910158760387

Q36688932-1DE578D7-5F45-4690-AA33-50E31391861D

Q36688932-256D40B8-E331-479A-A4BB-528B6D8F769D

Q36688932-2E6DF175-B3C6-40EE-9665-205ED2E5C77E

Q36688932-3243CC0F-C28D-4786-861F-42D662A1DC21

P304

Q36688932-6768B7DA-AA2F-4C7B-9D05-1AA68CBBF17D

P31

Q36688932-F2FBF6CB-5480-4B5E-B39A-AB2149C81172

P356

Q36688932-B5989C48-9473-4D65-8EFA-850DDC4B4073

P407

Q36688932-2A45A31A-AB0F-40D6-BE34-D31C5A8FE20B

P433

Q36688932-34B9FD32-AE51-4271-9CC1-8B08C40A2274

P478

Q36688932-3E432C7D-DA55-478E-A3FD-95CD6DE79831

P50

Q36688932-47CC0371-301A-4863-BED7-2A312933D82D

P577

Q36688932-BB179BF1-8740-408A-AEE7-5FD575A60D45

P5875

Q36688932-5B9833B7-D4F4-4588-98CC-3568B41362ED

P698

Q36688932-F8DCB1FE-6403-4E90-A5F6-0D0004477665

P932

Q36688932-E74AC7D9-A0F9-4854-808B-EC2656AE9520

P356

ONCOTARGET.6628

P1433

P1476

Enhancement of adoptive T cell ...... orubicin or paclitaxel in mice

@en

P2093

Hui-Yen Chuang

http://www.w3.org/2001/XMLSchema#string

Jeng-Jong Hwang

http://www.w3.org/2001/XMLSchema#string

Tzu-Chun Chen

http://www.w3.org/2001/XMLSchema#string

Ya-Fang Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for cancer: building on success

Cancer immunoediting from immune surveillance to immune escape

Adoptive T cell therapy for cancer in the clinic

Serial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironment

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

The transcription factor nuclear factor-kappa B and cancer

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

NF-kappaB and IKK as therapeutic targets in cancer

Transforming growth factor-beta regulation of immune responses

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

P304

44134-44150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6628

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287482879

http://www.w3.org/2001/XMLSchema#string

P698

26683520

http://www.w3.org/2001/XMLSchema#string

P932

4792547

http://www.w3.org/2001/XMLSchema#string